×

Why Gilead isn't soaring

5:12 PM ET Wed, 23 July 2014

Gilead Sciences reported Q2 EPS of $2.36 ex-items on revenue of $6.53 billion, with $3.48 billion sales of Sovaldi. CNBC's Meg Tirrell reports the highlights from the conference call.